1. Home
  2. AADI vs NAII Comparison

AADI vs NAII Comparison

Compare AADI & NAII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AADI
  • NAII
  • Stock Information
  • Founded
  • AADI 2011
  • NAII 1980
  • Country
  • AADI United States
  • NAII United States
  • Employees
  • AADI N/A
  • NAII N/A
  • Industry
  • AADI Biotechnology: Pharmaceutical Preparations
  • NAII Medicinal Chemicals and Botanical Products
  • Sector
  • AADI Health Care
  • NAII Health Care
  • Exchange
  • AADI Nasdaq
  • NAII Nasdaq
  • Market Cap
  • AADI 33.6M
  • NAII 34.5M
  • IPO Year
  • AADI N/A
  • NAII 1987
  • Fundamental
  • Price
  • AADI $1.56
  • NAII $5.84
  • Analyst Decision
  • AADI Buy
  • NAII
  • Analyst Count
  • AADI 2
  • NAII 0
  • Target Price
  • AADI $5.00
  • NAII N/A
  • AVG Volume (30 Days)
  • AADI 340.3K
  • NAII 4.4K
  • Earning Date
  • AADI 08-07-2024
  • NAII 05-14-2024
  • Dividend Yield
  • AADI N/A
  • NAII N/A
  • EPS Growth
  • AADI N/A
  • NAII N/A
  • EPS
  • AADI N/A
  • NAII N/A
  • Revenue
  • AADI $23,840,000.00
  • NAII $120,201,000.00
  • Revenue This Year
  • AADI $4.21
  • NAII N/A
  • Revenue Next Year
  • AADI $8.61
  • NAII N/A
  • P/E Ratio
  • AADI N/A
  • NAII N/A
  • Revenue Growth
  • AADI 26.97
  • NAII N/A
  • 52 Week Low
  • AADI $1.28
  • NAII $5.06
  • 52 Week High
  • AADI $7.24
  • NAII $7.62
  • Technical
  • Relative Strength Index (RSI)
  • AADI 46.27
  • NAII 43.57
  • Support Level
  • AADI $1.32
  • NAII $5.63
  • Resistance Level
  • AADI $1.55
  • NAII $5.88
  • Average True Range (ATR)
  • AADI 0.10
  • NAII 0.19
  • MACD
  • AADI 0.01
  • NAII -0.01
  • Stochastic Oscillator
  • AADI 46.15
  • NAII 43.27

About AADI Aadi Bioscience Inc.

Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site. It has one operating segment, which is the business of developing and commercializing proprietary therapeutic. Geographically, it is located in the United States.

About NAII Natural Alternatives International Inc.

Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segment. The company derives the majority of revenue from Private-Label Contract Manufacturing which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.

Share on Social Networks: